View the lecture recording here.
JoAnn E. Manson, MD, MPH, DrPH
Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health, Harvard Medical School; Chief of the Division of Preventive Medicine and Co-Director, Connors Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital
October 29th, 2015
(D) Amphitheater, Armenise Building
210 Longwood Avenue
Boston, MA 02115
Register here. This event is free and open to the public.
Three areas of major clinical controversy in primary prevention are the use of aspirin, estrogen therapy (in postmenopausal women), and vitamin D supplementation. Although conclusive answers to settle these ongoing debates remain elusive, recent evidence has emerged to inform clinical decision making for each of these issues. Available evidence will be reviewed, with particular emphasis on results from randomized clinical trials.
JoAnn E. Manson, MD, MPH, DrPH, is Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health at Harvard Medical School. She is also Chief of the Division of Preventive Medicine and Co-Director, Connors Center for Women’s Health and Gender Biology, at Brigham and Women’s Hospital. Dr. Manson is an endocrinologist, epidemiologist, and Principal Investigator of several NIH-funded research studies, including the Women’s Health Initiative Clinical Center In Boston (since study inception); the VITamin D and OmegA-3 TriaL (VITAL); and the cardiovascular component of the Nurses’ Health Study. She is also one of the Principal Investigators of the Kronos Early Estrogen Prevention Study and the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). Her primary research interests include randomized clinical prevention trials; effects of endogenous and exogenous estrogen on cardiovascular disease, diabetes, and other chronic diseases; the role of lifestyle and nutritional factors, including vitamin D and omega-3s, in the prevention of chronic diseases; effects of moderate-intensity versus vigorous exercise; the benefits and risks of aspirin; and the role of biochemical and genetic factors in predicting chronic disease risk. Dr. Manson has received numerous honors, including the Woman in Science Award from the American Medical Women’s Association, the American Heart Association’s (AHA) Population Research Prize, the AHA’s Distinguished Scientist Award, election to the Institute of Medicine of the National Academies (National Academy of Medicine), membership in the Association of American Physicians (AAP) ,and the 2013 Bernadine Healy Award for Visionary Leadership in Women’s Health. She served as the 2011-2012 President of the North American Menopause Society (NAMS). She has published more than 800 articles and is the author or editor of several books. She was also one of the physicians featured in the National Library of Medicine’s exhibition, History of American Women Physicians.
Please contact Kim Ripley at BostonMedLibr@gmail.com or 617-432-4807 with any questions.